Daratumumab Plus Bortezomib, Thalidomide, and Dexamethasone (D-VTd) in Transplant-eligible Newly Diagnosed Multiple Myeloma (NDMM): Subgroup Analysis of High-risk Patients (Pts) in CASSIOPEIA

Pieter Sonneveld; Michel Attal; Aurore Perrot; Cyrille Hulin; Denis Caillot; Thierry Facon; Xavier Leleu; Karim Belhadj-Merzoug; Lionel Karlin; Lofti Benboubker; Mark-David Levin; Monique Minnema; Matthijs Westerman; Michel Delforge; Sonja Zweegman; Lixia Pei; Carla de Boer; Veronique Vanquickelberghe; Tobias Kampfenkel; Philippe Moreau

Daratumumab Plus Bortezomib, Thalidomide, and Dexamethasone (D-VTd) in Transplant-eligible Newly Diagnosed Multiple Myeloma (NDMM): Subgroup Analysis of High-risk Patients (Pts) in CASSIOPEIA

Pieter Sonneveld
, Michel Attal
, Aurore Perrot
, Cyrille Hulin
, Denis Caillot
, Thierry Facon
, Xavier Leleu
, Karim Belhadj-Merzoug
, Lionel Karlin
, Lofti Benboubker
, Mark-David Levin
, Monique Minnema
, Matthijs Westerman
, Michel Delforge
, Sonja Zweegman
, Lixia Pei
, Carla de Boer
, Veronique Vanquickelberghe
, Tobias Kampfenkel
, Philippe Moreau

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	E2-E3
Journal	Clinical Lymphoma, Myeloma and Leukemia
Volume	19
Issue number	10
Publication status	Published - Oct 2019

Keywords

daratumumab
Multiple myeloma
transplant

Cite this

Sonneveld, P., Attal, M., Perrot, A., Hulin, C., Caillot, D., Facon, T., Leleu, X., Belhadj-Merzoug, K., Karlin, L., Benboubker, L., Levin, M.-D., Minnema, M., Westerman, M., Delforge, M., Zweegman, S., Pei, L., de Boer, C., Vanquickelberghe, V., Kampfenkel, T., & Moreau, P. (2019). Daratumumab Plus Bortezomib, Thalidomide, and Dexamethasone (D-VTd) in Transplant-eligible Newly Diagnosed Multiple Myeloma (NDMM): Subgroup Analysis of High-risk Patients (Pts) in CASSIOPEIA. Clinical Lymphoma, Myeloma and Leukemia, 19(10), E2-E3.

@article{01b0e7a91baa44a3b2a9b5975e9b6eb6,

title = "Daratumumab Plus Bortezomib, Thalidomide, and Dexamethasone (D-VTd) in Transplant-eligible Newly Diagnosed Multiple Myeloma (NDMM): Subgroup Analysis of High-risk Patients (Pts) in CASSIOPEIA",

keywords = "daratumumab, Multiple myeloma, transplant",

author = "Pieter Sonneveld and Michel Attal and Aurore Perrot and Cyrille Hulin and Denis Caillot and Thierry Facon and Xavier Leleu and Karim Belhadj-Merzoug and Lionel Karlin and Lofti Benboubker and Mark-David Levin and Monique Minnema and Matthijs Westerman and Michel Delforge and Sonja Zweegman and Lixia Pei and \{de Boer\}, Carla and Veronique Vanquickelberghe and Tobias Kampfenkel and Philippe Moreau",

year = "2019",

month = oct,

language = "English",

volume = "19",

pages = "E2--E3",

journal = "Clinical Lymphoma, Myeloma and Leukemia",

issn = "2152-2650",

publisher = "Elsevier",

number = "10",

}

Sonneveld, P, Attal, M, Perrot, A, Hulin, C, Caillot, D, Facon, T, Leleu, X, Belhadj-Merzoug, K, Karlin, L, Benboubker, L, Levin, M-D, Minnema, M, Westerman, M, Delforge, M, Zweegman, S, Pei, L, de Boer, C, Vanquickelberghe, V, Kampfenkel, T & Moreau, P 2019, 'Daratumumab Plus Bortezomib, Thalidomide, and Dexamethasone (D-VTd) in Transplant-eligible Newly Diagnosed Multiple Myeloma (NDMM): Subgroup Analysis of High-risk Patients (Pts) in CASSIOPEIA', Clinical Lymphoma, Myeloma and Leukemia, vol. 19, no. 10, pp. E2-E3.

Daratumumab Plus Bortezomib, Thalidomide, and Dexamethasone (D-VTd) in Transplant-eligible Newly Diagnosed Multiple Myeloma (NDMM): Subgroup Analysis of High-risk Patients (Pts) in CASSIOPEIA. / Sonneveld, Pieter; Attal, Michel; Perrot, Aurore et al.
In: Clinical Lymphoma, Myeloma and Leukemia, Vol. 19, No. 10, 10.2019, p. E2-E3.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - Daratumumab Plus Bortezomib, Thalidomide, and Dexamethasone (D-VTd) in Transplant-eligible Newly Diagnosed Multiple Myeloma (NDMM): Subgroup Analysis of High-risk Patients (Pts) in CASSIOPEIA

AU - Sonneveld, Pieter

AU - Attal, Michel

AU - Perrot, Aurore

AU - Hulin, Cyrille

AU - Caillot, Denis

AU - Facon, Thierry

AU - Leleu, Xavier

AU - Belhadj-Merzoug, Karim

AU - Karlin, Lionel

AU - Benboubker, Lofti

AU - Levin, Mark-David

AU - Minnema, Monique

AU - Westerman, Matthijs

AU - Delforge, Michel

AU - Zweegman, Sonja

AU - Pei, Lixia

AU - de Boer, Carla

AU - Vanquickelberghe, Veronique

AU - Kampfenkel, Tobias

AU - Moreau, Philippe

PY - 2019/10

Y1 - 2019/10

KW - daratumumab

KW - Multiple myeloma

KW - transplant

M3 - Meeting Abstract

SN - 2152-2650

VL - 19

SP - E2-E3

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

IS - 10

ER -